AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2009 by Amgen.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Amgen
Information provided by:
Amgen
ClinicalTrials.gov Identifier:
NCT00089674
First received: August 9, 2004
Last updated: December 3, 2009
Last verified: December 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2010 |
| Primary Completion Date: | June 2008 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | November 23, 2009 |